Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
PharmaShots
Top 20 Generic Companies of 2026
Shots: 20. Alkem Generic Segment Revenue: $1.64B Founded Year: 1973 Market Cap: $6.67B Total Employees: 19,300 Headquarters: Maharashtra, India Stock Exchange: NSE 19. Towa Pharmaceutical Co Generic Segment Revenue: $1.72B Founded Year: 1951 Market Cap: $1.22B Total Employees: 4,900 Headquarters: Osaka, Japan Stock Exchange: TYO 18. Amneal Generic Segment Revenue: $1.74B Founded Year: 2002 Market Cap: $6.02B Total Employees: 8,700 Headquarters: New Jersey, United States Stock Exchange: NASDAQ 17. Stada Generic Segment… The post Top 20 Generic Companies of 2026 appeared first on PharmaShots.
Read Full Article
Pharma Tech
Immunology specialist Khartis Therapeutics emerges from stealth with $95m
Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.
Read Full Article
Pharma Tech
BMS secures FDA accelerated approval for Zenbexus in multiple myeloma
The FDA has granted accelerated approval to BMS' Zenbexus, along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma.
Read Full Article
Pharma Tech
Xanadu and University of Alberta to develop quantum algorithms for cancer
Xanadu Quantum Technologies and the University of Alberta in Canada partnered to advance algorithms to treat cancer.
Read Full Article
Express Pharma
Why India’s medicines need integrated authentication, enforceable standards
Triggered by recent high profile operations involving counterfeit semaglutide in the domestic markets and anti-rabies vaccines exported to various countries, India’s regulators are plugging the gaps by expanding the existing QR code mandate and may next require online registration of manufacturers and suppliers of printed pharma packaging materials. However, Ankit Gupta, President, ASPA explains to Viveka Rychowdhury, that as counterfeiters evolve, isolated security measures should be replaced with integrated authentication ecosystems and enforceable standards The post Why India’s medicines need integrated authentication, enforceable standards appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Aug 16, 2026, 9:20 AM
Dr Reddy’s formulations facility gets 4 observations from FDA
In an intimation to the stock exchange, the company said its Bachupally, Hyderabad-based formulations manufacturing facility (FTO-3) underwent an inspection from August 6 to 14 and have been issued a Form 483 with four observations.
ET Pharma
Aug 15, 2026, 1:38 AM
Drugmakers curb Swiss reimbursement applications over US pricing concerns
About one-third of new innovative medicines were not submitted for coverage under Switzerland's mandatory health insurance system between January 2025 and June 2026, according to a survey by Swiss pharmaceutical industry group Interpharma, potentially limiting patient access to new treatments.
PharmaShots
Aug 14, 2026, 1:30 PM
Top 20 Generic Companies of 2026
Shots: 20. Alkem Generic Segment Revenue: $1.64B Founded Year: 1973 Market Cap: $6.67B Total Employees: 19,300 Headquarters: Maharashtra, India Stock Exchange: NSE 19. Towa Pharmaceutical Co Generic Segment Revenue: $1.72B Founded Year: 1951 Market Cap: $1.22B Total Employees: 4,900 Headquarters: Osaka, Japan Stock Exchange: TYO 18. Amneal Generic Segment Revenue: $1.74B Founded Year: 2002 Market Cap: $6.02B Total Employees: 8,700 Headquarters: New Jersey, United States Stock Exchange: NASDAQ 17. Stada Generic Segment… The post Top 20 Generic Companies of 2026 appeared first on PharmaShots.
PharmaShots
Aug 14, 2026, 12:30 PM
Rigel Reports Availability of Veppanu for ER+/HER2-, ESR1-Mutated Breast Cancer
Shots: Ref: PRnewswire | Image: Rigel | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Rigel Reports Availability of Veppanu for ER+/HER2-, ESR1-Mutated Breast Cancer appeared first on PharmaShots.
PharmaShots
Aug 14, 2026, 11:30 AM
ArkBio’s Ziresovir Secures the US FDA Approval for P-II Trial in RSV Infant Patients
Shots: Ref: PRnewswire | Image: ArkBio | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post ArkBio’s Ziresovir Secures the US FDA Approval for P-II Trial in RSV Infant Patients appeared first on PharmaShots.
PharmaShots
Aug 14, 2026, 10:30 AM
Zoetis’ Simparica Trio Receives FDA’s EUA for Treating New World Screwworm Infestations in Dogs and Puppies
Shots: Ref: Businesswire | Image: Zoetis | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Zoetis’ Simparica Trio Receives FDA’s EUA for Treating New World Screwworm Infestations in Dogs and Puppies appeared first on PharmaShots.
News
Latest industry coverage
Google News
Aug 16, 2026, 1:00 PM
'Not of Standard Quality' Drug Case: J&K High Court Refuses Relief to Pharma Directors - Medical Dialogues
'Not of Standard Quality' Drug Case: J&K High Court Refuses Relief to Pharma Directors Medical Dialogues
Google News
Aug 16, 2026, 12:31 PM
The week in pharma: action, reaction and insight – week to August 14, 2026 - The Pharma Letter
The week in pharma: action, reaction and insight – week to August 14, 2026 The Pharma Letter
Google News
Aug 16, 2026, 11:06 AM
National Women Commission Conclave in West Bengal: Women could be key entrepreneurs in pharma sector - organiser.org
National Women Commission Conclave in West Bengal: Women could be key entrepreneurs in pharma sector organiser.org
Google News
Aug 16, 2026, 10:03 AM
Same Drug, Different Brand, Different MRP? Centre Explains Pricing Rules Under DPCO - Medical Dialogues
Same Drug, Different Brand, Different MRP? Centre Explains Pricing Rules Under DPCO Medical Dialogues
Google News
Aug 16, 2026, 9:51 AM
Glenmark USA Agrees to USD 15.28 Mn Settlement With Humana Over Generic Drug Antitrust Claims - Medical Dialogues
Glenmark USA Agrees to USD 15.28 Mn Settlement With Humana Over Generic Drug Antitrust Claims Medical Dialogues
Google News
Aug 16, 2026, 9:41 AM
Thermo Fisher Eyes 15-20% Growth in India Customer Base Over Next 5 Years Amid Biopharma Boom - Medical Dialogues
Thermo Fisher Eyes 15-20% Growth in India Customer Base Over Next 5 Years Amid Biopharma Boom Medical Dialogues
Google News
Aug 16, 2026, 9:19 AM
Libya Explores Joining African Pooled Purchasing Mechanism - Libya Herald
Libya Explores Joining African Pooled Purchasing Mechanism Libya Herald
Google News
Aug 16, 2026, 9:15 AM
Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside (NYSE:TMO) - Seeking Alpha
Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside (NYSE:TMO) Seeking Alpha
Google News
Aug 16, 2026, 6:39 AM
Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination - The Clinical Trial Vanguard
Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination The Clinical Trial Vanguard
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer